| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.588 | 28.615 | 30.887 | 34.378 | 39.566 | 51.389 | 73.220 | 102.474 | 94.257 | 87.630 |
| Total Income - EUR | 24.588 | 28.615 | 30.890 | 34.380 | 39.570 | 51.412 | 73.264 | 102.483 | 95.471 | 87.631 |
| Total Expenses - EUR | 18.979 | 25.602 | 21.146 | 26.076 | 33.248 | 42.500 | 44.583 | 62.084 | 57.589 | 69.810 |
| Gross Profit/Loss - EUR | 5.609 | 3.013 | 9.744 | 8.305 | 6.322 | 8.912 | 28.681 | 40.399 | 37.882 | 17.821 |
| Net Profit/Loss - EUR | 4.871 | 2.155 | 8.817 | 7.273 | 5.135 | 7.446 | 27.410 | 39.374 | 36.927 | 15.191 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 |
Check the financial reports for the company - Endomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.154 | 35.164 | 25.125 | 19.880 | 9.745 | 8.666 | 6.253 | 124.667 | 119.819 | 120.256 |
| Current Assets | 19.590 | 6.894 | 21.968 | 26.748 | 41.474 | 55.512 | 68.683 | 15.437 | 19.213 | 5.637 |
| Inventories | 0 | 0 | 0 | 232 | 228 | 223 | 218 | 0 | 0 | 0 |
| Receivables | 1.879 | 1.730 | 2.638 | 3.406 | 4.823 | 4.743 | 8.047 | 10.654 | 13.281 | 2.054 |
| Cash | 17.712 | 5.164 | 19.330 | 23.110 | 36.424 | 50.546 | 60.417 | 4.783 | 5.932 | 3.583 |
| Shareholders Funds | 29.504 | 31.358 | 39.644 | 46.190 | 45.689 | 52.269 | 73.264 | 112.865 | 125.191 | 111.538 |
| Social Capital | 159 | 157 | 155 | 152 | 149 | 146 | 143 | 143 | 143 | 142 |
| Debts | 240 | 10.700 | 7.449 | 438 | 5.530 | 11.909 | 1.672 | 27.239 | 13.841 | 14.355 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endomed Srl